0001209191-17-043425.txt : 20170705
0001209191-17-043425.hdr.sgml : 20170705
20170705174754
ACCESSION NUMBER: 0001209191-17-043425
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170703
FILED AS OF DATE: 20170705
DATE AS OF CHANGE: 20170705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dimension Therapeutics, Inc.
CENTRAL INDEX KEY: 0001592288
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463942159
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-401-0011
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jenkins Annalisa
CENTRAL INDEX KEY: 0001639481
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37601
FILM NUMBER: 17948739
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34715 ARDENWOOD BLVD, SUITE 100
CITY: FREMONT
STATE: CA
ZIP: 94555
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-03
0
0001592288
Dimension Therapeutics, Inc.
DMTX
0001639481
Jenkins Annalisa
C/O DIMENSION THERAPEUTICS, INC.
840 MEMORIAL DRIVE, 4TH FLOOR
CAMBRIDGE
MA
02139
1
1
0
0
President and CEO
Stock Option (Right to Buy)
1.35
2017-07-03
4
A
0
150000
0.00
A
2027-07-02
Common Stock
150000
150000
D
This option shall vest on December 31, 2018, subject to the Reporting Person's continued service to the Issuer on such date.
/s/ Jean Franchi, as Attorney-in-Fact for Annalisa Jenkins
2017-07-05